Literature DB >> 10644329

The human cytomegalovirus major immediate-early distal enhancer region is required for efficient viral replication and immediate-early gene expression.

J L Meier1, J A Pruessner.   

Abstract

The human cytomegalovirus (HCMV) major immediate-early (MIE) genes, encoding IE1 p72 and IE2 p86, are activated by a complex enhancer region (base positions -65 to -550) that operates in a cell type- and differentiation-dependent manner. The expression of MIE genes is required for HCMV replication. Previous studies analyzing functions of MIE promoter-enhancer segments suggest that the distal enhancer region variably modifies MIE promoter activity, depending on cell type, stimuli, or state of differentiation. To further understand the mechanism by which the MIE promoter is regulated, we constructed and analyzed several different recombinant HCMVs that lack the distal enhancer region (-300 to -582, -640, or -1108). In human fibroblasts, the HCMVs without the distal enhancer replicate normally at high multiplicity of infection (MOI) but replicate poorly at low MOI in comparison to wild-type virus (WT) or HCMVs that lack the neighboring upstream unique region and modulator (-582 or -640 to -1108). The growth aberrancy was normalized after restoring the distal enhancer in a virus lacking this region. For HCMVs without a distal enhancer, the impairment in replication at low MOI corresponds to a deficiency in production of MIE RNAs compared to WT or virus lacking the unique region and modulator. An underproduction of viral US3 RNA was also evident at low MOI. Whether lower production of IE1 p72 and IE2 p86 causes a reduction in expression of the immediate-early (IE) class US3 gene remains to be determined. We conclude that the MIE distal enhancer region possesses a mechanism for augmenting viral IE gene expression and genome replication at low MOI, but this regulatory function is unnecessary at high MOI.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10644329      PMCID: PMC111634          DOI: 10.1128/jvi.74.4.1602-1613.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  57 in total

1.  A strong negative transcriptional regulatory region between the human cytomegalovirus UL127 gene and the major immediate-early enhancer.

Authors:  C A Lundquist; J L Meier; M F Stinski
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

2.  Characterization of a BHK(TK-) cell clone resistant to postattachment entry by herpes simplex virus types 1 and 2.

Authors:  R J Roller; B C Herold
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

3.  Developmental analysis of the cytomegalovirus enhancer in transgenic animals.

Authors:  J F Baskar; P P Smith; G S Ciment; S Hoffmann; C Tucker; D J Tenney; A M Colberg-Poley; J A Nelson; P Ghazal
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

4.  Human cytomegalovirus latent infection of granulocyte-macrophage progenitors.

Authors:  K Kondo; H Kaneshima; E S Mocarski
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-06       Impact factor: 11.205

5.  Gfi-1 encodes a nuclear zinc finger protein that binds DNA and functions as a transcriptional repressor.

Authors:  P A Zweidler-Mckay; H L Grimes; M M Flubacher; P N Tsichlis
Journal:  Mol Cell Biol       Date:  1996-08       Impact factor: 4.272

6.  Characterization of the sequences of the human cytomegalovirus enhancer that mediate differential regulation by natural and synthetic retinoids.

Authors:  A Angulo; C Suto; R A Heyman; P Ghazal
Journal:  Mol Endocrinol       Date:  1996-07

7.  Cytomegalovirus replicates in differentiated but not in undifferentiated human embryonal carcinoma cells.

Authors:  E Gönczöl; P W Andrews; S A Plotkin
Journal:  Science       Date:  1984-04-13       Impact factor: 47.728

8.  Four of eleven loci required for transient complementation of human cytomegalovirus DNA replication cooperate to activate expression of replication genes.

Authors:  A C Iskenderian; L Huang; A Reilly; R M Stenberg; D G Anders
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

9.  Regulation of a human cytomegalovirus immediate-early gene (US3) by a silencer-enhancer combination.

Authors:  A R Thrower; G C Bullock; J E Bissell; M F Stinski
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

10.  Detection of cytomegalovirus DNA in CD34+ cells from blood and bone marrow.

Authors:  D von Laer; U Meyer-Koenig; A Serr; J Finke; L Kanz; A A Fauser; D Neumann-Haefelin; W Brugger; F T Hufert
Journal:  Blood       Date:  1995-12-01       Impact factor: 22.113

View more
  43 in total

1.  A strong negative transcriptional regulatory region between the human cytomegalovirus UL127 gene and the major immediate-early enhancer.

Authors:  C A Lundquist; J L Meier; M F Stinski
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

2.  The human cytomegalovirus major immediate-early enhancer determines the efficiency of immediate-early gene transcription and viral replication in permissive cells at low multiplicity of infection.

Authors:  Hiroki Isomura; Mark F Stinski
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

3.  Role of the proximal enhancer of the major immediate-early promoter in human cytomegalovirus replication.

Authors:  Hiroki Isomura; Tatsuya Tsurumi; Mark F Stinski
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

4.  Regulation of the transcription and replication cycle of human cytomegalovirus is insensitive to genetic elimination of the cognate NF-kappaB binding sites in the enhancer.

Authors:  Montse Gustems; Eva Borst; Chris A Benedict; Carmen Pérez; Martin Messerle; Peter Ghazal; Ana Angulo
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

5.  The late promoter of the human cytomegalovirus viral DNA polymerase processivity factor has an impact on delayed early and late viral gene products but not on viral DNA synthesis.

Authors:  Hiroki Isomura; Mark F Stinski; Ayumi Kudoh; Sanae Nakayama; Satoko Iwahori; Yoshitaka Sato; Tatsuya Tsurumi
Journal:  J Virol       Date:  2007-04-04       Impact factor: 5.103

Review 6.  Role of the cytomegalovirus major immediate early enhancer in acute infection and reactivation from latency.

Authors:  Mark F Stinski; Hiroki Isomura
Journal:  Med Microbiol Immunol       Date:  2007-12-19       Impact factor: 3.402

7.  Prolonged activation of NF-kappaB by human cytomegalovirus promotes efficient viral replication and late gene expression.

Authors:  Ian B DeMeritt; Jagat P Podduturi; A Michael Tilley; Maciej T Nogalski; Andrew D Yurochko
Journal:  Virology       Date:  2005-11-21       Impact factor: 3.616

8.  Lytic but not latent infection by Kaposi's sarcoma-associated herpesvirus requires host CSL protein, the mediator of Notch signaling.

Authors:  Yuying Liang; Don Ganem
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-27       Impact factor: 11.205

9.  Activation of the NF-kappaB pathway in human cytomegalovirus-infected cells is necessary for efficient transactivation of the major immediate-early promoter.

Authors:  Ian B DeMeritt; Liesl E Milford; Andrew D Yurochko
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

10.  The human cytomegalovirus UL76 gene regulates the level of expression of the UL77 gene.

Authors:  Hiroki Isomura; Mark F Stinski; Takayuki Murata; Sanae Nakayama; Shigeki Chiba; Yoshiki Akatsuka; Teru Kanda; Tatsuya Tsurumi
Journal:  PLoS One       Date:  2010-07-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.